Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal CancerThomas Reinert, Claus L. Andersen, Tenna Vesterman Henriksen et al.|JAMA Oncology|2019Cited by 992
ctDNA guiding adjuvant immunotherapy in urothelial carcinomaThomas Powles, Sanjeev Mariathasan, Peter Albers et al.|Nature|2021Cited by 603
Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder CarcinomaEmil Christensen, Lars Dyrskjøt, Karin Birkenkamp‐Demtröder et al.|Journal of Clinical Oncology|2019Cited by 540
Updated Overall Survival by Circulating Tumor DNA Status from the Phase 3 IMvigor010 Trial: Adjuvant Atezolizumab Versus Observation in Muscle-invasive Urothelial CarcinomaThomas Powles, Sanjeev Mariathasan, Zoe J. Assaf et al.|European Urology|2023Cited by 128
Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric CancersBrandon M. Huffman, Samuel J. Klempner, Vasily N. Aushev et al.|JCO Precision Oncology|2022Cited by 72